"Ozempic face" — characteristic facial volume loss following rapid GLP-1 medication-induced weight loss — has emerged as a major aesthetic concern as these medications mainstream. The pattern includes hollow temples, flattened cheeks, deepened nasolabial folds, sunken under-eyes, and visible jawline edge that often reads as jowling. Korean cosmetic medicine offers refined approaches to address this specific volume loss pattern. This guide covers the practical considerations.
What "Ozempic face" actually is
- Facial volume loss following rapid weight loss from GLP-1 medications.
- Not unique to GLP-1 — occurs with any rapid weight loss.
- GLP-1 patients typically experience approximately 9% midface volume loss.
- Pattern includes specific compartments more affected than others.
- Different from gradual menopausal aging.
- Often patient looks years older despite improved body composition.
Why GLP-1 weight loss accelerates facial aging
- Rapid fat loss without gradual skin and tissue adaptation.
- Facial fat compartments deflate substantially.
- Loss exceeds natural aging trajectory.
- Skin and ligamentous support don\'t retract proportionally.
- Underlying skeletal structure becomes more visible.
The characteristic pattern
- Temple hollowing — visible depression at temples.
- Mid-face flattening — cheek volume loss.
- Nasolabial deepening — folds appear more prominent.
- Under-eye hollowing — tear trough deepens.
- Jawline visibility — bone definition increases but with jowl appearance.
- Marionette lines — peri-oral lines deepen.
- Skin laxity — without underlying fat support.
Treatment timing considerations
During active weight loss
- Conservative approach — facial volume continues changing.
- Topical care, sunscreen, gentle skin treatments.
- Avoid major volume restoration that may need adjustment.
- Skin booster injections may be useful.
Weight loss plateau (3+ months stable)
- Volume restoration becomes appropriate.
- Conservative initial filler placement.
- Assess response and adjust.
- Comprehensive multi-modal approach feasible.
Long-term weight maintenance (1+ year stable)
- Full treatment options including surgical considerations.
- Fat grafting if substantial restoration needed.
- Surgical lift consideration for significant skin laxity.
- Long-term maintenance planning.
Treatment options matched to severity
Mild Ozempic face
- Mid-face HA filler.
- Temple filler.
- Skin boosters.
- Maintenance every 12–18 months.
Moderate Ozempic face
- Comprehensive HA filler placement.
- Sculptra collagen stimulation.
- HIFU/RF for skin tightening.
- Combined approach.
Significant Ozempic face
- Fat grafting for substantial volume restoration.
- Combined with thread lift or surgical lift.
- Comprehensive multi-modal treatment.
- Long-term planning.
The Korean approach
Korean clinics emphasize:
- Wait for weight stabilization before major intervention.
- Address dominant compartment deflation rather than generic filler.
- Fat grafting often preferred over excessive filler accumulation.
- Combined volume + tightening for skin laxity component.
- Long-term maintenance commitment recognition.
Common Korean combination protocols
- Mid-face filler + temple filler + skin booster — entry-level approach.
- Sculptra full face + HIFU — moderate cases.
- Fat grafting + skin tightening — substantial cases.
- Comprehensive surgery + fat grafting + maintenance — significant cases.
For specific GLP-1 patient profiles
Active GLP-1 user planning continued use
- Treatment after weight stabilization.
- Conservative volume initially.
- Adjust as continued use stabilizes weight.
- Coordinate with prescribing physician.
Discontinued GLP-1 with weight regain
- Wait for weight stabilization in either direction.
- Avoid treatment during regain phase.
- Reassess facial appearance after stable weight.
Long-term GLP-1 maintenance user
- Stable weight allows full treatment options.
- Annual or biannual volume maintenance.
- Comprehensive aesthetic plan.
- Coordinated with overall medical management.
What about the body changes?
Beyond the face, GLP-1 weight loss affects:
- Body composition with skin laxity in some patients.
- Buttock, thigh, abdomen volume changes.
- Breast volume changes in women.
- Combined with body contouring planning sometimes.
- Coordinated body and face treatment for comprehensive patients.
What patients should avoid
- Premature filler before weight stabilization.
- Excessive volume restoration creating "pillow face."
- Single procedure expecting comprehensive correction.
- Discontinuing GLP-1 specifically to address facial changes (overall health goals matter more).
The skin laxity component
- Volume restoration alone may not address all visible aging.
- Skin laxity from rapid weight loss responds to:
- HIFU for moderate laxity.
- Thread lift for early laxity.
- Surgical lift for established laxity.
- Combined with volume for comprehensive treatment.
What to ask in your consultation
- Has my weight stabilized adequately for treatment?
- What specific compartments are deflated in my case?
- What approach matches my severity?
- How does ongoing GLP-1 use affect treatment planning?
- What is the realistic outcome and maintenance commitment?
Pricing in Korea (2026, USD)
- Comprehensive mid-face filler: $1,500–$4,000.
- Combined face + temple + tear trough: $2,500–$6,000.
- Sculptra series: $1,500–$3,500.
- Comprehensive fat grafting: $4,500–$9,000.
- Combined fat grafting + skin tightening: $7,000–$13,000.
- Full surgical approach for severe cases: $14,000–$28,000+.
For international patients
- Plan around stable weight period.
- Coordinate with home country GLP-1 prescribing physician.
- Comprehensive Korean approach for substantial change.
- Maintenance planning for ongoing care.
The honest framing
"Ozempic face" is a real and increasingly common concern as GLP-1 medications mainstream. Korean cosmetic surgery offers refined approaches matched to the specific volume loss pattern. The patients who achieve best results wait for weight stabilization, address dominant compartment deflation rather than generic filler, combine volume restoration with skin tightening when laxity is present, and commit to long-term maintenance. The goal is not reversing the weight-loss benefits but supporting facial appearance through the body composition changes the medication produces. Coordinated medical and aesthetic management produces the most sustainable results.